Stelexis Therapeutics

Stelexis Therapeutics is a cancer therapeutics company, which utilizes its proprietary platform to selectively target pre-cancerous stem cells to discover and develop transformative therapies. The Company's proprietary drug discovery platform identifies definable pre-cancerous stem and progenitor cells that lead to the formation of human primary and recurrent tumors for therapeutic intervention and relapse prevention.